Search Results
133 Results for 'Drug Discovery & Development'
PAGE 2 OF 6
Technology
VACO6
A UW-Madison researcher has established a cell line, called VACO6, from a discarded tissue specimen of a surgically resected primary human colon cancer. The detailed characteristics of the clinical do...
Learn More
Learn More
James Willson | P230180US01
Technology
A NOVEL STRATEGY ENABLED BY A PHOTO-CLEAVABLE SURFACTANT FOR EXTRACELLULAR VESICLE PROTEOMICS
Building off of their prior discovery (Photo-Cleavable Surfactants P180335US02), UW-Madison researchers disclose an improved method for exosome proteomics. The method leverages the researchers’ phot...
Learn More
Learn More
Ying Ge, Song Jin, Kyle Brown, Kevin Buck | P220113US02
Technology
UW-Madison researchers have developed a titin DNA construct (a ‘titin minigene plasmid’) that is useful for identifying agents that modulate the titin size reduction that correlates with age and l...
Learn More
Learn More
Wei Guo, Yanghai Zhang | P230097US01
Technology
METHOD FOR DIFFERENTIATION OF BRAIN MURAL CELLS FROM HUMAN PLURIPOTENT STEM CELLS
UW-Madison researchers disclose a new method for differentiating brain mural cells – encompassing pericytes and vascular smooth muscle cells – from hPSCs. The inventors used their previously discl...
Learn More
Learn More
Eric Shusta, Benjamin Gastfriend, Sean Palecek | P220005US02
Technology
Primatized Mouse
The present invention is a novel, primatized mouse model for studying the immune system of nonhuman primates in a relatively low-cost mouse. The UW-Madison inventor used a different source of immune c...
Learn More
Learn More
Matthew Brown | P210237US02
Technology
Organelle-Targeted Genetically-Encoded Voltage Indicators And Methods Of Use Thereof
UW researchers have developed modified genetically encoded plasma membrane voltage probes for monitoring mitochondrial and ER membrane voltage gradients. A fluorescence protein tag was coupled with a ...
Learn More
Learn More
Meyer Jackson, Masoud Sepehri Rad | P210400US02
Technology
Knockout of GFAP In the Mouse (Model tm1Mes)
UW-Madison researchers have developed a GFAP knockout mouse model, designated tm1Mes, that has been engineered to have an internal deletion of the Gfap gene that renders it completely non-functional. ...
Learn More
Learn More
Albee Messing, Maureen McCall | P220164US01
Technology
SARS-COV-2 OMICRON BA.2 VARIANT FOR MEDICAL COUNTERMEASURE EVALUATION
UW-Madison researchers have isolated and characterized a BA.2 strain of the Omicron variant of SARS-CoV-2.
Learn More
Learn More
Yoshihiro Kawaoka | P220198US01
Technology
SARS-COV-2 BA.1 OMICRON VARIANT FOR MEDICAL COUNTERMEASURE EVALUATION
UW-Madison researchers have isolated and characterized a BA.1 strain of the Omicron variant of SARS-CoV-2.
Learn More
Learn More
Yoshihiro Kawaoka, Peter Halfmann | P220159US01
Technology
Mouse Model of Alexander Disease (Model B6.129S7 (Cg) Gfap tm2Mes)
UW-Madison researchers have developed a mouse model of Alexander disease, designated B6.129S7 (Cg) Gfap tm2Mes, that was engineered as a knock-in of the R236H point mutation in the Gfap gene; this is ...
Learn More
Learn More
Albee Messing, Tracy Hagemann | P220167US01
Technology
Mouse Model of Alexander Disease (Model FVB.129S7 (Cg) Gfap tm2Mes)
UW-Madison researchers have developed a mouse model of Alexander disease, designated FVB.129S7 (Cg) Gfap tm2Mes, that was engineered as a knock-in of the R236H point mutation in the Gfap gene; this is...
Learn More
Learn More
Albee Messing, Tracy Hagemann | P220165US01
Technology
Transgenic Mouse Expressing Human GFAP (Model Tg73.7)
UW-Madison researchers have developed a transgenic mouse, designated Tg73.7, that carries full-length copies of a human genomic clone of wild-type GFAP, including all introns and exons.
Learn More
Learn More
Albee Messing, Michael Brenner | P220166US01
Technology
Mouse Model of Alexander Disease (Model FVB.129S7 (Cg) Gfap tm3Mes)
UW-Madison researchers have developed a mouse model of Alexander disease, designated FVB.129S7 (Cg) Gfap tm3Mes, that was engineered as a knock-in of the R76H point mutation in the Gfap gene. This is ...
Learn More
Learn More
Albee Messing, Tracy Hagemann | P220169US01
Technology
CHEMICAL COCKTAIL FOR INDUCING SENESCENCE IN HUMAN NEURONS TO PROMOTE DISEASE MODELING AND DRUG DISCOVERY
Provided herein are methods and compositions for inducing chemical senescence in neurons and methods of using chemically induced senescent neurons for modeling neurodegenerative disease and drug disco...
Learn More
Learn More
Su-Chun Zhang, Ali Fathi | P200006US02
Technology
METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES
Described herein are methods, compositions, and kits for directed differentiation of human pluripotent stem cells, neuromesodermal progenitors, and neural stem cells into bioengineered elliptical neur...
Learn More
Learn More
Randolph Ashton, Gavin Knight, Benjamin Knudsen, Nisha Iyer, Carlos Marti-Figueroa | P200307US03
Technology
GENERATION OF NOREPINEPHRINE NEURONS FROM HUMAN STEM CELLS
Methods for obtaining populations of norepinephrine (NE) neuronal progenitor cells and creating enriched populations of NE neurons are provided herein. Also provided herein are methods for obtaining g...
Learn More
Learn More
Su-Chun Zhang, Yunlong Tao | P200364US02
Technology
Cell-Based Assay for Identifying Inhibitors of Viral Translational Recoding
Viruses maximize their genetic potential through several mechanisms including expressing multiple protein products from a single mRNA template. A crucial mechanism is conserved by both retroviruses, i...
Learn More
Learn More
Nathan Sherer, Bayleigh Benner | P200340US01
Technology
PLASMID ENCODING INFECTIOUS RHINOVIRUS-C GENOTYPE C45
UW-Madison researchers have cloned, sequenced and characterized the genome from an isolate of the RV-C45 genotype, and they’ve provided the cDNA for a high titer HRV-C (C45-2A-D41K), as well as the ...
Learn More
Learn More
Ann Palmenberg | P210398US01
Technology
RPE CELL LINES WITH PLK4 CONDITIONAL KNOCKOUT AND ANALOG SENSITIVE MUTATION
UW-Madison researchers have developed two cell lines derived from RPE-1 cells (which were obtained from ATCC), an immortalized, non-transformed human epithelial cell line. “PLK4 WTflox/Delta” is a...
Learn More
Learn More
Mark Burkard, Ryan Denu | P210364US01
Technology
CHO Cell Line Expressing HERG-1 Potassium Channels
HERG-1 (human ether-a-go-go-related gene) potassium channels mediate repolarization of cardiac action potentials. Loss of function mutations in hERG-1 can result in long QT syndrome, an inherited diso...
Learn More
Learn More
Gail Robertson, Barry Ganetzky, Jeffrey Warmke, Matthew Trudeau, Samuel Breit, Terence Campbell, Bruce Walker, Stella Valenzuela | P00082US
Technology
Fluorescent-Tagged Moraxella Catarrhalis For Cell Culture Experiments
The present invention is a fluorescence-based cell assay for studying the replication of Moraxella catarrhalis. UW-Madison researchers developed a bacterial strain that fluoresces red by producing the...
Learn More
Learn More
Cameron Currie, Reed Stubbendieck | P210244US01
Technology
Plasmids And Cell Lines Expressing The DMPK 3'UTR
The UW Madison researchers' invention is a set of plasmid constructs and cell lines developed to investigate the effects of RNA toxicity in myotonic dystrophy. The inventor created two constructs ...
Learn More
Learn More
Mani Mahadevan, Jeffrey Amack | P210221US01
Technology
Enhanced Neoglycosides Through Neoglycosylation And Methods Of Use Thereof
Using neoglycosylation, the impact of differential glycosylation upon the divergent anticancer and anti-HIV properties of the triterpenoid betulinic acid (BA) was examined. Each member from a library ...
Learn More
Learn More
Jon Thorson, Randal Goff | P07498US02
Technology
Reversible Natural Product Glycosyltransferase-catalyzed Reactions, Compounds And Related Methods
The present invention relates to methods of use of glycosyltransferases and related compounds. The invention exploits the reversibility of glycosyltransferases to generate new sugars, unnatural biomol...
Learn More
Learn More
Jon Thorson, Byron Griffith, Changsheng Zhang | P06427US
Technology
Compositions,m Ethods And Devices For Preparing Less Painful Botulinum Toxin Formulations
Devices, methods and kits are disclosed for preparing and administering less-painful formulations of Botulinum toxin. The devices, methods and kits of the present invention are comprised of or use an ...
Learn More
Learn More
Gary Borodic, Martin Acquadro | P05406US